Page last updated: 2024-08-21

adamantane and mdl 100907

adamantane has been researched along with mdl 100907 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ettrup, A; Farde, L; Finnema, SJ; Halldin, C; Knudsen, GM; Martinsson, S; Stepanov, V; Takano, A; Yang, KC	1

Other Studies

1 other study(ies) available for adamantane and mdl 100907

Article	Year
Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain. The international journal of neuropsychopharmacology, 2017, 09-01, Volume: 20, Issue:9 Topics: Adamantane; Aminoquinolines; Animals; Benzylamines; Brain; Brain Mapping; Dose-Response Relationship, Drug; Female; Fenfluramine; Fluorobenzenes; Macaca mulatta; Magnetic Resonance Imaging; Phenethylamines; Piperidines; Positron-Emission Tomography; Protein Binding; Purinergic P2X Receptor Antagonists; Receptor, Serotonin, 5-HT2A; Serotonin Agents	2017

Article

Year

Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain.

The international journal of neuropsychopharmacology, 2017, 09-01, Volume: 20, Issue:9

Topics: Adamantane; Aminoquinolines; Animals; Benzylamines; Brain; Brain Mapping; Dose-Response Relationship, Drug; Female; Fenfluramine; Fluorobenzenes; Macaca mulatta; Magnetic Resonance Imaging; Phenethylamines; Piperidines; Positron-Emission Tomography; Protein Binding; Purinergic P2X Receptor Antagonists; Receptor, Serotonin, 5-HT2A; Serotonin Agents

2017